| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 11.206 | 14.334 | 14.444 | 12.048 | 5.835 | 12.919 |
| Total Income - EUR | - | - | - | - | 11.206 | 14.359 | 14.444 | 13.439 | 5.835 | 12.919 |
| Total Expenses - EUR | - | - | - | - | 3.496 | 5.578 | 6.359 | 6.730 | 3.317 | 3.890 |
| Gross Profit/Loss - EUR | - | - | - | - | 7.711 | 8.781 | 8.085 | 6.709 | 2.519 | 9.029 |
| Net Profit/Loss - EUR | - | - | - | - | 7.420 | 8.581 | 7.725 | 6.366 | 1.953 | 7.509 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Ivoderm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 4.058 | 2.954 | 1.461 | 1.390 | 790 | 291 |
| Current Assets | - | - | - | - | 8.927 | 10.071 | 12.735 | 7.170 | 2.613 | 9.024 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 761 | 708 | 1.790 |
| Cash | - | - | - | - | 8.927 | 10.071 | 12.735 | 6.408 | 1.905 | 7.233 |
| Shareholders Funds | - | - | - | - | 3.247 | 5.978 | 13.570 | 6.595 | 2.001 | 7.557 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 9.737 | 7.048 | 626 | 860 | 727 | 1.510 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 1.105 | 675 | 247 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ivoderm S.r.l.